Background
==========

Primary liver cancer, also known as hepatocellular carcinoma (HCC), happens to be the sixth most common cancer as well as the third leading cause of cancer mortality in the world \[[@B1]\]. The incidence of HCC is on the rise in multiple geographic areas, including Asia Pacific, sub-Saharan Africa, Southern Europe as well as North America. It has been estimated that there will be more than 22,000 new cases and about 18,000 deaths in the United States in 2009 due to liver cancer which represents about 4% of cancer mortality in this country \[[@B2]\]. The vast majority of HCC cases are attributable to underlying infections caused by the hepatitis B and C viruses \[[@B3]\], nevertheless several other risk factors, namely alcoholism, as well as dietary carcinogens, such as aflatoxins and nitrosamines are also involved in its etiology \[[@B4],[@B5]\].

In this work we are interested on aflatoxins (AF), a group of mycotoxins which are common contaminants in a wide variety of food. AF are produced as secondary metabolites by Aspergillus flavus and Aspergillus parasiticus fungi. AF not only contaminate our food stuffs but are also found in edible tissues, milk and eggs after consumption of contaminated feed by farm animals \[[@B6],[@B7]\]. AF are the collective term for four major naturally occurring secondary compounds (B1, B2, G1 and G2). Aflatoxins B1 (AFB1) is the most potent of these toxins, which has hepatotoxic and hepatocarcinogenic properties \[[@B8]\]. The International Agency for Research on Cancer IARC classified AFB1 and mixtures of aflatoxins as Group 1 carcinogens \[[@B9]\]. The liver is the main target organ for AF and chronic exposure to low levels in foodstuffs causes liver fibrosis and primary liver cancer \[[@B10]\]. It is metabolized in the liver producing the formation of highly reactive chemical intermediaries. The carcinogenic mechanism of AFB1 has been extensively studied. It has been shown that AFB1 is activated by hepatic cytochrome P450 enzyme system to produce a highly reactive intermediate, AFB1-8,9-epoxide, which subsequently binds to nucleophilic sites in DNA, and the major adduct 8,9-dihydro-8 (N7guanyl)- 9-hydroxy-AFB1 (AFB1 N7-Gua) is formed \[[@B11],[@B12]\]. In addition its genotoxic proprieties, it can induce oxidative stress both \"*in vivo*\" and \"*in vitro*\" \[[@B13],[@B14]\]. In view of the limited treatment and grave prognosis of liver cancer, preventive control approaches, notably chemoprevention, have been considered as one of the best strategies in lowering the current morbidity and mortality associated with HCC \[[@B15],[@B16]\]. A detailed understanding of the pathogenesis of HCC holds the promise of finding an effective and novel strategy for the chemoprevention and treatment of liver cancer. Recently, natural foods and food derived antioxidants such as vitamins and phenolic phytochemicals have received growing attention, because they are known to function as chemopreventive agents against oxidative damage and genotoxicity. Fruits, vegetables and herb medicines contain many antioxidant compounds, including carotenoids, thiols vitamins such as ascorbic acid, tocopherols, flavonoids, and other phenolics \[[@B17]\]. Active principles with diverse chemical structures have been isolated from plants reportedly possessing hepatoprotective effects. Cactus *Opuntia ficus indica*, a member of the Cactaceae family, is an important forage crop for livestock in many arid and semi-arid regions of the world. It is widely distributed in Mexico and in all American hemispheres as well as in Africa and in the Mediterranean basin \[[@B18]\]. Fruit and cladode of this plant yield high values of important nutrients such as minerals, vitamins as well as further antioxidants \[[@B19]-[@B22]\]. Besides, several studies have reported its efficiency in the treatment of several diseases. These fruits have shown several effect such as antiulcerogenic \[[@B23]\], antioxidant \[[@B23]-[@B25]\], anticancer \[[@B26]\] and hepatoprotective activities \[[@B27]\]. Different parts of *Opuntia ficus-indica*are used in the traditional medicine of several countries: the cladodes are utilized for treatment of ulcers, rheumatic pain, wounds, fatigue; in addition, in our laboratory a recent study showed the potential antigenotoxic activities of cactus cladodes against single dose of the mycotoxin zearalenone (ZEN), a potent estrogenic metabolite \[[@B28]\]. These data have made cactus pear fruits and cladodes perfect candidates for cytoprotective investigations.

The aim of the present study was to find out the eventual protective effect of CCE against AFB1-induced hepatotoxicity *in vivo*using Balb/c mice. We evaluated the oxidative status, the mutagenic and the genotoxic potential of AFB1 alone or jointly with CCE. To this end, we measured MDA concentrations, the protein carbonyls generation and heat shock protein (Hsp70 and Hsp 27) expressions. We also evaluated chromosome aberrations, DNA fragmentation, mutagenic activity, p53, bax and bcl2 protein expressions.

Materials and methods
=====================

Chemicals
---------

AFB1 was obtained from Sigma Chemical Co. (USA). Dimethyl sulfoxide (DMSO) was obtained from Sigma Chemical Co. (St Louis, MO, USA). Nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate disodium salt (BCIP) were from Sigma Aldrich, France. Goat anti-mouse alkaline phosphatase conjugate antibody, mouse anti-Hsp 70 and anti-Hsp 27 monoclonals antibody (SPA-80) were from Stressgen, USA. Mouse monoclonal anti-p53, anti-bax and anti-bcl2 and the secondary antibody (phosphatase-conjugated) were from Invitrogen. Gen Elute \"Mammalian genomic DNA Miniprep Kit sufficient for 70 purifications\" was purchased from Sigma AIdrich, USA. All other chemicals used were of the highest grade available from commercial sources.

Extract of cactus cladodes
--------------------------

Young cactus cladodes of *Opuntia ficus-indica*(2-3 weeks of age) collected from the local area were washed with water chopped into small pieces and then pressed using a hand-press, homogenized in 10 mM Tris-HCl, pH 7.4 at 4°C and centrifuged 30 min at 3500 g at 4°C. The supernatant was collected, dried and stored at -20°C.

Animals and treatments
----------------------

Adult, healthy balbC (20-25 g) male mice provided from an animal breeding centre (SEXAL, St. Doulchard, France following the agreement of the Ethics Committee named National committee of Medical ethics CNEM, BP 74 - Pasteur Institute Tunis 1002 TUNISIA) were used. The animals were kept for acclimatization 1 week under constant conditions of temperature and a light/dark cycle of 12 h: 12 h. Animals had free access to standard granulated chow and drinking water. Animals were pre-treated by intraperitonial administration of CCE (50 mg/Kg.b.w) for 2 weeks. Control animals were treated 3 days a week for 4 weeks by intraperitonial administration of 250 μg/Kg.b.w AFB1. Animals treated by AFB1 and CCE were divided into two groups: the first group was administrated CCE 2 hours before each treatment with AFB1 3 days a week for 4 weeks. The second group was administrated without pre-treatment with CCE but the extract was administrated 24 hours after each treatment with AFB1 3 days a week for 4 weeks.

All animals were divided in 9 groups of 6 animals per group and treated as follows:

Group 1: Mice given H2O (100 μl)

Group 2: Mice given DMSO/H2O (1:1, v: v)

Group 3: Mice given CCE 50 mg/Kg b.w

Group 4: Mice given AFB1 250 μg/Kg b.w for15 days treatment

Group 5: Mice given AFB1 250 μg/Kg b.w + CCE 50 mg/Kg b.w (before 15 days treatment by AFB1)

Group 6: Mice given AFB1 250 μg/Kg b.w + CCE 50 mg/Kg b.w (after 15 days treatment by AFB1)

Group 7: Mice given AFB1 250 μg/Kg b.w for 30 days treatment

Group 8: Mice given AFB1 250 μg/Kg b.w + CCE 50 mg/Kg b.w (before 30 days treatment by AFB1)

Group 9: Mice given AFB1 250 μg/Kg b.w + CCE 50 mg/Kg b.w (after 30 days treatment by AFB1).

Preparation of liver extracts
-----------------------------

Livers of mice were homogenized with a Potter (glass-Teflon) in the presence of 10 mM Tris-HCl, pH 7.4 at 4°C and centrifuged at 4000 rpm for 30 min at 4°C. The supernatant was collected for analysis and the protein concentration was determined in liver extract using Protein BioRad assay \[[@B29]\].

Evaluation of lipid peroxidation status
---------------------------------------

Lipid peroxidation was determined indirectly by measuring the production of MDA in the liver extracts following the method of Aust et al. (1985) \[[@B30]\]. Briefly, 200 μl of liver extracts were mixed with 150 μl of TBS (Tris 50 mM and NaCl 150 mM, pH 7.4) and 250 μl TCA-BHT (20% TCA and BHT 1%). The mixture was vigorously vortexed and centrifuged at 1500 g for 10 min. 400 μl of the supernatant were added with HCl 0.6 N and 320 μl Tris-TBA (Tris 26 mM and TBA 120 mM), the content was mixed and incubated 10 min at 80°C. The absorbance was measured at 535 nm. The optic density corresponding to the complex formed with the TBA-MDA is proportional to the concentration of MDA and to the lipid peroxide. The concentration of μmol of MDA/mg of proteins is calculated from the absorbance at 530 nm using the molar extinction coefficient of MDA 1.56 × 10^5^M^-1^cm^-1^.

Protein carbonyl assay
----------------------

Protein carbonyls content was determined as described by Mercier et al. (2004) \[[@B31]\] in liver homogenates by measuring the reactivity of carbonyl groups with 2,4-dinitrophenylhydrazine (2,4-DNPH). Thus, 200 μl of supernatant of liver were placed in glass tubes. 800 μl of 10 mM DNPH in 2.5 M HCl were added. Tubes were left for 1 h of incubation at room temperature in the dark. Samples were vortexed every 15 min. Then 1 ml of 20% TCA was added to samples, and the tubes were left in ice bucket for 10 min and centrifuged for 5 min at 4000 rpm to collect the protein precipates and the supernatants were discarded. Next, another wash is performed using 1 ml of 10% TCA, and protein pellets are broken mechanically with the aid of glass rod. Finally, the pellets are washed with 1 ml of ethanol-ethyl acetate (1:1, v/v) to remove the free DNPH. The final precipitates are dissolved in 500 μl of guanidine hydrochloride 6 M and are left for 10 min at 37°C with general vortex mixing. Any insoluble materials are removed by additional centrifugation. Protein carbonyls concentration was determined from the absorbance at 370 nm, applying the molar extinction coefficient of 22.0 Mm ^-1^cm^-1^. A range of nmoles of carbonyls per ml is usually obtained for most proteins and is related to the protein content in the pellets.

Protein extraction and Western blot analysis
--------------------------------------------

Equal amounts of proteins (20 μg) were separated by 12% SDS-polyacrylamide gel electrophoresis. Separated proteins were electro-blotted on nitrocellulose membrane in the transfer buffer (10 ml Tris-base, pH 8.3, 96 mM glycine and 10% methanol). The membrane was then blocked in TBS (20 mM Tris-HCl, Ph 7.5, 500 mM sodium chloride) containing 5% of BSA, washed in TTBS (TBS containing 0.3% Tween 20) and probed with an antibody for anti-Hsp 70, anti-Hsp 27, anti-p53, anti-bax and anti-bcl2 at a 1:1000 dilution for 6 h at room temperature. The membrane was washed and incubated with goat anti-mouse alkaline phosphate conjugated at a 1:3000 dilution for 1 h. finally, the membrane was washed and the chromogenic substrate BCIP/NBT was added to localize antibody binding. Hsp 70, Hsp 27, p53, bax and bcl2 levels were then determined by computer-assisted densitometric analysis (Densitometer, GS-800, BioRad Quantity One).

Chromosome aberrations assay
----------------------------

24 hours before sacrifice, animals were given a suspension of yeast powder (100 mg/500 μl) to accelerate mitosis of bone-marrow cells. Vinblastine (200 μl; 250 μg/ml) was injected into the animals 45 min before sacrifice in order to block dividing cells in metaphasis. Bone marrow cells from femurs and tibias were collected, subjected to hypotonic shock (KCl 0.075 M) and fixed three times using methanol-acetic acid \[[@B32]\]. The cells were spread on glass slides that were blazed on a flame for 5 s, then air-dried for conservation at room temperature and finally stained by 4% dilution of Giemsa reagent in water for 15 min. After coding of the slides, the chromosomes of 100 cells in metaphase were examined for abnormalities at a magnification of 1000 × using an optical microscope (Carl Zeiss, Germany).

This was done for each one of three replicates (300 metaphases per dose level) for negative controls, positive controls and treated groups. Chromosome aberrations were identified according to criteria described by Savage (1975) \[[@B33]\]. Metaphases with chromosome breaks, gaps, rings and centric fusions (robertsonian translocation) were recorded and expressed as percentage of total metaphases per group.

Detection of fragmented DNA by agarose gel electrophoresis
----------------------------------------------------------

Mammalian tissues (livers) were lysed with a chaotropic salt-containing buffer to ensure denaturation of macromolecules. DNA is bound to the spin column membrane and the remaining lysate is removed by centrifugation. A filtration column is used to remove cell debris, after washing to remove contaminants; the DNA is eluted with buffer into a collection tube. The pellet was rinsed with 70% ethanol, dried at room temperature for 2 h and resuspended in 200 μl of TE (20 mM Tris-HCl pH 8.0,1 mM EDTA). Loading buffer was added to 10 μg of DNA for each treatment, and the samples were analyzed by electrophoresis on a 1% agarose gel (1 h at 80 V/30 mA) with a TBE running buffer (44 mM Tris-HCl,44 mM boric acid, 50 mM EDTA, pH8.0).

Quantitative analysis of DNA samples was performed by UV spectrophotometry (1 OD = 50 μg DNA ml-1, max = 258 to 260 nm). Each DNA sample was prepared and stored at -80°C prior to use.

Activation mixture
------------------

The S9 microsome fraction was prepared from the liver of rats treated with Aroclor 1254 \[[@B34]\]. The composition of the activation mixture is the following per 10 ml of S9 mix: salt solution (1.65 M KCl + 0.4 M MgCl2 - 6H2O) 0.2 ml; G6P (1 M) 0.05 ml; NADP (0.1 M) 0.15 ml; Tris buffer (0.4 M pH7.4) 2.5 ml; Luria broth medium 6.1 ml; S9 fraction 1 ml.

SOS chromotest
--------------

The SOS chromotest assay is a bacterial test for detecting DNA damaging agent. It was employed to determine the effect of cactus cladode extract on the genotoxicity of aflatoxin B1 (direct acting mutagen) induced genotoxicity. The SOS chromotest with Escherichia coli PQ37strain was performed according to the procedure described by Quillardet and Hofnung (1985) \[[@B35]\]. The genotype of this strain is: F-thr leu his-4 pyrD thi galE galK lacDU169 Srl300Tn10 rpoB rpsL uvrA rfa trp Muc + sfiA::Mud (Ap, lac) cts. An exponential-phase culture of E. coli PQ37 was grown at 37°C in LB medium to an approximate cell density of 2.10^8^cell/ml supplemented with ampicillin (20 μg/ml). One ml of this culture was diluted with 9 ml of fresh medium; Positive controls were prepared by exposure of the bacteria to AFB1. After 2 h of incubation at 37°C, with shaking, 300 μl samples were used for assaying β- galactosidase (β-gal) and alkaline phosphatase (AP) activities. In this assay, the β-galactosidase synthesis (lacZ gene) is dependent on sfiA activation and is used to measure induction of SOS repair system. The activity of the constitutive enzyme alkaline phosphatise was used as a measure of protein synthesis and toxicity.

Enzyme activities were assessed spectrophotometrically. The SOS induction factor (IF) in treated cells was obtained by comparing β-galactosidase and alkaline phosphatase activities in treated and untreated cells. The result was considered positive when the IF for β-galactosidase activity was \> 2.0. For evaluation of the protective effect of CCE on the induction of the SOS response by AFB1 (in the presence of the S9 activation mixture), 10 μl of AFB1 (10 μg/assay) were added into tubes with 10 μl of the tested concentration of CCE.

Antigenotoxicity was expressed as percentage inhibition of genotoxicity induced by AFB1 according to the formula: % = 100 - (IF1 - IF0/IF2 - IF0) \*100

Where IF1 is the induction factor in the presence of the test compound and the genotoxin, IF2 the induction factor in the absence of the test compound and in the presence of the genotoxin, and IF0 is the induction factor of the negative control. Data were collected as a mean ± S.D. of experiments.

Statistical analysis
--------------------

Each experiment was carried out in triplicates. Data are expressed as means ± standard deviation (S.D.). Differences between groups were determined using one-way ANOVA with Bonferroni\'s post multiple comparisons, Expression of Hsp 70, Hsp 27, p53, bax and bcl2 were determined by Kruskal-Wallis Test. The level of significance was accepted with P \< 0.05 was used for statistical analysis.

Results
=======

Effect of CCE on oxidative stress induced by AFB1
-------------------------------------------------

### Evaluation of lipid peroxidation status

Results of the effect of AFB1 alone and jointly with CCE on the induction of lipid peroxidation in liver as determined by MDA level are shown in Figure [1](#F1){ref-type="fig"}, AFB1 induced a significant increase in MDA formation as compared to control groups especially on day 30. The MDA level increased from a basal level of 11.05 ± 0.25 lM/mg of protein to reach 25.50 ± 0.15 l M/mg of protein and 38.15 ± 0.75 l M/mg on days 15 and 30 respectively. The increase in MDA levels was about two folds as compared to the control group (p \< 0.05). Interestingly, when animals were treated with CCE (50 mg/kg b.w) a sharp decrease in MDA level was noticed in both 15 day and 30 day times. For a pre and post-treatment effect, MDA level has decreased significantly to reach the control level.

![**Lipid peroxydation as determined by MDA level in liver of Balb/c mice exposed to AFB1 (250 μg/Kg b.w.) for 15 days then 30 days and prevention by cactus cladode extract (50 mg/Kg b.w) before or after AFB1 administration**. Results were expressed as means ± S.D. from independent experiments. (\*) indicated significant difference (p \< 0.05) from control.](1743-7075-8-73-1){#F1}

### Protein carbonyl assay

Protein carbonyls formation, indicative of severe protein oxidation was assayed in liver homogenates and results are illustrated in Figure [2](#F2){ref-type="fig"}. AFB1 generates protein carbonyls formation as compared to control groups in liver extracts. Indeed, the protein carbonyls level increases from basal value of 5.25 ± 0.10 nmol/mg of protein in control group to reach 15.50 ± 0.04 nmol/mg of protein and 22.45 ± 0.03 nmol/mg of protein in AFB1 treated group after respectively 15 and 30 days of treatment. The cactus cladodes extract remarkably decreased protein carbonyls formation induced by AFB1 (250 μg/Kg b.w.) by 60% in liver extracts.

![**Concentrations of protein carbonyls in liver of treated mice with AFB1 (250 μg/Kg b.w.)**. Cytoprotective effects of cactus cladodes extract (50 mg/Kg b.w.) before or after treatment with AFB1. Data are exposed as the means ± S.D.](1743-7075-8-73-2){#F2}

### Determination of Hsp70 and Hsp27expressions

Figures [3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"} show the western blotting and densitometry analysis of hsp70 expression in livers of control and treated animals. AFB1-exposed mice showed significantly increased expression of hsp70 after 15 days and remarkably after 30 days exposure on liver extract compared to control groups. Administration of CCE before or after AFB1 exposure decreased significantly the hsp70 expression. This decrease reached the basal expression observed in control groups. Similar results were found for Hsp 27 expression (Figures [4a](#F4){ref-type="fig"} and [4b](#F4){ref-type="fig"})

![**Immunoblot (a) and densitometric (b) analysis of Hsp 70 in liver of control and treated animals**. The protein was separated on 12% SDS-PAGE and blotted with anti-Hsp70 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different as compared to controls (p \< 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days treatment.](1743-7075-8-73-3){#F3}

![**Immunoblot (a) and densitometric (b) analysis of Hsp 27 in liver of control and treated animals**. The protein was separated on 12% SDS-PAGE and blotted with anti-Hsp 27 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different as compared to controls (p \< 0.005).](1743-7075-8-73-4){#F4}

Effect of CCE on DNA damage induced by AFB1
-------------------------------------------

### Eventual prevention of *AFB1-induced*chromosome aberrations by CCE

Genotoxicity of AFB1 was assessed through test of chromosome aberrations in mice bone marrow cells. Results of the visual scoring of total DNA damage induced by AFB1 are shown in Figure [5](#F5){ref-type="fig"}. We observed that animals treated with AFB1 alone (250 μg/kg b.w) showed a significant increase in chromosome aberrations in bone marrow cells especially on day 30 with 35% of chromosome aberrations. Control groups which were treated with H2O, H2O/DMSO or CCE showed a similar basal and low percentage of total chromosome aberrations (respectively 1.67 ± 0.18; 2.33 ± 1.56 and 2 ± 0.15). But we remarked that the coadministration of cactus before or after AFB1 treatment decreased significantly the total chromosomal aberrations. Meanwhile, the protection by cactus extract was not total; it reached 60% (Figure [5](#F5){ref-type="fig"}).

![**Effect of cactus cladodes on chromosomal aberrations in bone marrow cells of AFB1 treated Balb/c mice**. Results are expressed as mean ± standard deviation (n = 3). (\*) indicated significant difference (p \< 0.05) from control.](1743-7075-8-73-5){#F5}

### Eventual prevention of *AFB1-induced*DNA fragmentation by CCE

Results obtained after agarose gel electrophoresis are shown in Figure [6](#F6){ref-type="fig"}; No specific DNA fragments were observed for control groups (lanes 1, 2, 3). Animals treated by AFB1 (250 μg/kg b.w) for 15 days and 30 days (lanes 4 and 7 respectively) showed a significant DNA fragmentation in liver cells. Simultaneous treatment of mice with CCE before or after AFB1 exposure for 15 days and 30 days showed a significant restoration of DNA (lanes 5, 6, 8 and 9 respectively).

![**DNA fragmentation of mice liver extracts induced by AFB1 and prevention of CCE revealed by agarose gel electrophoresis**. The results are representative of nine lines: MW: Markers (MW = 1 Kb). (1) Animals treated by 100 μl H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days treatment.](1743-7075-8-73-6){#F6}

### The SOS Chromotest assay

Experiments realized with CCE revealed no genotoxicity induction in so far as the induction factor is not higher than 1.5. While experiment with AFB1 gave the maximum of genotoxicity with IF = 4.24. The inhibitory effect of the tested product on the genotoxicity induced by AFB1using the SOS chromotest is illustrated by table [1](#T1){ref-type="table"}. This study shows that CCE present an antigenotoxic effect at the tested concentrations. Indeed CCE significantly decreases the IF of AFB1 by 64%.

###### 

Genotoxic activity of CCE and AFB1 by the SOS Chromotest in the presence of E.coli PQ37.

  Extract        β-gal (U)   AP (U)   IF
  -------------- ----------- -------- ------
  **NC**         1,65        1,9      
  **AFB1**       9,21        2,5      4,24
  **CCE**        1,1         1,7      0,73
  **AFB1+CCE**   1,56        1,25     1,42

β-gal: β-galactosidase; AP: alkaline phosphatase; U: enzyme units; IF: induction factor; NC: negative control (non treated cells).

Effect of CCE on apoptose status
--------------------------------

### Determination of p53 expression

Figures [7a](#F7){ref-type="fig"} and [7b](#F7){ref-type="fig"} show the Western blotting and densitometry analysis of p53 expression in liver of controls and treated animals. After 15 days and 30 days exposure to AFB1 alone, p53 expression was found to be significantly increased compared to controls but it decreased by CCE pre or post-treatment. The CCE treated group did not have any significant effect on the expression of p53.

![**Immunoblot (a) and densitometric (b) analysis of p53 in liver of control and treated animals**. The protein was separated on 12% SDS-PAGE and blotted with anti-p53 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different as compared to controls (p \< 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days treatment.](1743-7075-8-73-7){#F7}

### Determination of bax expression

AFB1 induces the expression of bax in liver as evidenced by immunoblotting illustrated in Figure [8a](#F8){ref-type="fig"}, which was further, confirmed by results of scanning densitometry (Figure [8b](#F8){ref-type="fig"}). The administration of CCE before and after AFB1 exposure for 15 and 30 days treatment decreased the amounts of bax (Figure [8a](#F8){ref-type="fig"} and [8b](#F8){ref-type="fig"}). The CCE treated group did not show any significant modification on the expression of bax.

![**Immunoblot (a) and densitometric (b) analysis of bax in liver of control and treated animals**. The protein was separated on 12% SDS-PAGE and blotted with anti-bax antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different as compared to controls (p \< 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days treatment.](1743-7075-8-73-8){#F8}

### Determination of bcl2 expression

Figure [9a](#F9){ref-type="fig"} and [9b](#F9){ref-type="fig"} shows the western blotting and densitometry analysis of bcl2 expression in liver of controls and treated animals. After 15 days and 30 days exposure to AFB1 alone, anti-apoptotic protein bcl2 expression was found to be significantly decreased by 25% and 35% respectively after 15 and 30 days of AFB1 treatment compared to controls, but it increased before and after treatment by CCE. The CCE treated group did not show any significant modification on the expression of bcl2.

![**Immunoblot (a) and densitometric (b) analysis of bcl2 in liver of control and treated animals**. The protein was separated on 12% SDS-PAGE and blotted with anti-bcl2 antibody. The intensity of the protein band was scanned by densitometry. Results are significantly different as compared to controls (p \< 0.005). The results are representative of nine independent experiments: (1) Animals treated by 100 μl H2O. (2) Animals treated by mixture of DMSO/H2O (1:1; v:v). (3) Animals treated by CCE 50 mg/Kg b.w. (4) Animals treated 15 days by AFB1 250 μg/Kg b.w. (5) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 15 days treatment. (6) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 15 days treatment. (7) Animals treated 30 days by AFB1 250 μg/Kg b.w. (8) Animals treated by CCE 50 mg/Kg b.w before AFB1 250 μg/Kg b.w exposure for 30 days treatment. (9) Animals treated by CCE 50 mg/Kg b.w after AFB1 250 μg/Kg b.w exposure for 30 days treatment.](1743-7075-8-73-9){#F9}

Discussion
==========

Increasing attention has been given to the study of natural products, which may counteract the detrimental effects of environmental toxic compounds and prevent multiple human diseases. In this line, different types of fruits and vegetables have been re-evaluated and recognized as valuable sources of nutraceuticals. According to several studies, cactus pear (Opuntia ssp.) yield high values of important nutrients and exhibit antioxidant functions \[[@B25],[@B22]\]. In this work we evaluated the effect of CCE 50 mg/kg b.w tested in Balb/c by monitoring its effects on oxidative stress, genotoxicity and cell death pathway induced by sub-chronic treatment by AFB. We have chosen this dose based on previous reports which have proved its efficiency on preventing toxicity induced by the mycotoxin zearalenone \[[@B28]\]. Exposure to low levels of aflatoxins is one of the major risk factors in the etiology of human hepatocellular carcinoma. AFB1 is a potent hepatocarcinogen when given sub-chronically at a low level. Hence, we have chosen treatment by 250 μg/Kg b.w of AFB1 in sub-chronic condition \[[@B36]-[@B38]\]. To evaluate the oxidative status, we looked for an eventual lipid peroxidation. Determination of malondialdehyde (MDA) is considered to be an excellent index of lipid oxidation. The MDA is the end product of lipoperoxydation, considered as a late biomarker of oxidative stress and cellular damage \[[@B39],[@B40]\]. In the present study, exposure to AFB1 (250 μg/kg b.w) induced a marked increase in MDA level in liver (Figure [1](#F1){ref-type="fig"}). The oxidative damage caused by aflatoxin is considered to be the main mechanism leading to the subsequent hepatotoxicity \[[@B41]\]. AFB1 may disturb the integrity of cell membranes through stimulating phospholipid A2 to initiate lipid peroxidation in cells \[[@B42]\]. Results of others researches supported the earlier finding that AFs-induced oxidative stress and increased lipid peroxidation \[[@B43]\]. The pre and post-administration of CCE with AFB1 significantly reduced this oxidative effect which dropped to the control level.

To further assess AFB1 oxidative induced damages in Balb/c mice, the protein carbonyls generation was monitored. Protein carbonylation is a sign of irreversible oxidative damage, often leading to a loss of protein function, which may have lasting detrimental effects on cells and tissues \[[@B44],[@B45]\]. Our results clearly showed that AFB1 induced a marked increase in protein carbonyls generation in liver extracts which was significantly reduced with cactus extract in liver (Figure [2](#F2){ref-type="fig"}). Finally, to further study of oxidative stress in AFB1 induced toxicity, we choose to monitor early markers of oxidative stress. Nonspecific cellular oxidative damage is often observed during toxicity \[[@B46]\]. In fact, based on the analysis of MDA, protein carbonyls only (presumed late biomarkers of oxidative damage), it is difficult to determine whether severe oxidative stress is the cause or the consequence of cellular toxicity. Thus, levels of early markers of oxidative stress including antioxidant enzymes and Hsp, may be altered in the presence of lower levels of oxidative stress and before the biomarkers of severe oxidative stress attributed to cytotoxicity appear.

Hsps are induced and play a key role in cell protection and repair \[[@B47],[@B48]\]. This protein expression is triggered by structural damage caused to cell proteins mainly thiol oxidation and general perturbations of the cellular redox status level \[[@B49]-[@B51]\]. Several published data have reported that many sources of oxidative stress can lead to the up-regulation of the Hsp 70 as well as small Hsps such as Hsp 27 at levels where overt oxidative damage is not observed \[[@B52],[@B53]\]. Our results clearly demonstrated that treatment by AFB1 alone induced a sharp elevation in the expression level of both Hsp70 and Hsp 27 in liver of mice after 15 days and especially after 30 days treatment. Interestingly, when animals were treated by CCE before or after administration of AFB1, a sharp decrease of Hsp 70 and Hsp 27 levels was observed (Figure [3a, b](#F3){ref-type="fig"} and [4a, b](#F4){ref-type="fig"}). These results are in agreement with findings of Zourgui et al. (2008) \[[@B54]\] reporting that CCE was effective in the protection against acute toxicity induced by mycotoxin ZEN which increased Hsp 70 and Hsp 27 expressions in liver and kidney extracts. CCE ability to prevent and protect against oxidative damage is certainly associated to the presence of several antioxidants such as ascorbic acid, vitamin E, carotenoids, reduced glutathione, flavonoids and phenolic acids actually detected in fruits and vegetables of different varieties of cactus \[[@B55],[@B22],[@B56]\]. In addition, more recently, significant antioxidant properties of the most frequent cactus betalains have been revealed and numerous *in vitro*studies have demonstrated their ability to neutralize reactive oxygen species \[[@B21],[@B57],[@B25]\].

Oxidative stress is important as direct and indirect initiator as well as promoter of genotoxicity and apoptotic process. In order to elucidate the mechanism of genotoxic effect of AFB1, we have performed (i) the chromosome aberrations assay in bone marrow cells (ii) DNA fragmentation in liver and (iii) SOS Chromotest. Several studies have been conducted recently and have shown that AFB1 is a genotoxic agent. It has been shown that AFs especially AFB1 is activated by the hepatic cytochrome P450 enzyme system to produce a highly reactive intermediate, AFB1-8, 9-epoxide, which subsequently binds to nucleophilic sites in DNA and the major adduct 8, 9-dihydro-8-(N7guanyl)-9-hydroxy-AFB1 (AFB1 N7-Gua) is formed \[[@B11]\]. The formation of AFB1-DNA adducts is regarded as a critical step in the initiation of AFB1-induced hepatocarcinogenesis \[[@B58],[@B59]\]. The above genotoxic endpoints are well known markers of genotoxicity and any reduction in the frequency of these genotoxic endpoints gives an indication of the antigenotoxicity of a particular compound \[[@B60]\]. In the current study, we tested the chromosomal aberrations assay which is widely used test to assess genotoxicity of chemicals. We have demonstrated that mice receiving AFB1 showed a high percentage of chromosome aberrations in their bone marrow cells (Figure [5](#F5){ref-type="fig"}); mainly breaks. It is acknowledged that an increase in this frequency is associated with an increased overall risk of cancer \[[@B61],[@B62]\]. Most of the chromosomal aberrations observed in the cells are lethal, but there are many other aberrations that are viable and cause either somatic or inherited genetic effects \[[@B63]\]. There is a tendency for AFB1 to convert into the epoxide and produce DNA adducts that in turn cause DNA strand breaks and point mutations \[[@B64]\]. Mice pre and post-treated by CCE showed a significant reduction in the percentage of chromosome aberrations in their bone marrow cells and the protection was around 60% (Figure [5](#F5){ref-type="fig"}). To confirm the preventive effect of CCE against AFB1 genotoxicity, we looked for its eventual preventive effect against DNA fragmentation induced by AFB1. Indeed, we showed firstly that treatment with AFB1 (250 μg/kg b.w) induced a significant DNA fragmentation in liver cells of treated animals and no specific DNA fragments were observed for control. Simultaneous treatment of mice with AFB1 and CCE showed a significant restoration of DNA integrity (Figure [6](#F6){ref-type="fig"}). These results are in accordance with our recently published report involving preventive effect of CCE against genotoxicity induced by single intraperitonial treatment by the mycotoxin ZEN \[[@B28]\]. The protection, afforded by CCE against AFB1 genotoxicity is likely due to its ability to inhibit oxidative process induced by the mycotoxin AFB1. However, it could not be excluded that cactus extracts acts as antigenotoxic complex which enhances the DNA repair system or DNA synthesis. Among the studies performed in our laboratory we compared the prevention of ZEN genotoxic effects obtained by CCE to the prevention exerted by Vitamin E \[[@B65],[@B66]\] and by a variety of hydrated sodium calcium aluminosilicate clay (HSCAS) \[[@B67]\] described as a compound able to adsorb and to sequester ZEN leading to the reduction of toxin bioavailability \[[@B68]\]. CCE appears clearly more efficient then Vitamin E and clay HSCAS.

The antigenotoxic activity of CCE was investigated in our study and the nongenotoxicity of this extract was checked. CCE may act, as described for other polyphenols such as flavonoids, by inhibiting microsomal activation or by directly protecting DNA strands from the electrophilic metabolite of mutagen compounds. They may inhibit several metabolic intermediates and reactive oxygen species (ROS) formed during the process of microsomal enzyme activation which are capable of breaking DNA strands \[[@B69],[@B70]\].

The absence of genotoxicity is not a characteristic of all natural products in use; since other medicinal plants, tested with the SOS chromotest either in the presence or in the absence of the S9 preparation, have shown a genotoxic potential \[[@B71]\]. These tests showed that AFB1 present a genotoxic effect and that the treatment with CCE is able to diminish this genotoxicity (table [1](#T1){ref-type="table"}).

After ingestion, AFB1 was shown to be converted into its epoxide and this derivative produces DNA adducts causing DNA strand breaks and point mutations \[[@B64]\]. Under this pathological condition, the active process of cellular self destruction, apoptosis may occur.

In the present study, the modulator effect of CCE on AFB1 toxicity was suggested to could be attributed to some alterations in the cell death pathway. P53 and Bax/Bcl-2 ratios play an important role in determining whether cells will undergo apoptosis (Figure [7](#F7){ref-type="fig"}, Figure [10](#F10){ref-type="fig"}).

![**Bax/Bcl-2 expression ratio in liver of Balb/c mice exposed to AFB1 (250 μg/Kg b.w.) for 15 days then 30 days and prevention by cactus cladode extract (50 mg/Kg b.w) before or after AFB1 administration**. Results were expressed as means ± S.D. from independent experiments. (\*) indicated significant difference (p \< 0.05) from control.](1743-7075-8-73-10){#F10}

Our results showed that treatment by AFB1 for 15 and 30 days induced higher expressions of p53 and bax pro-apoptotic proteins in liver tissues of AFB1 treated mice than in control groups. The same treatment induced a down-regulation of the antiapoptotic protein bcl2 (Figures [7a, b](#F7){ref-type="fig"}, [8a, b](#F8){ref-type="fig"} and [9a, b](#F9){ref-type="fig"}). Similarly to our results, Ranchal et al. (2009) \[[@B72]\] reported that AFB1 induced DNA damage, reduced p27 expression and increased cell death in cultured hepatocytes. Meanwhile, the CCE treatment before or after AFB1, has been shown to induce an anti-apoptotic effect via inhibition of p53 and bax expression (Figures [7a, b](#F7){ref-type="fig"}, [8a, b](#F8){ref-type="fig"} and [9a, b](#F9){ref-type="fig"}). This indicates that CCE can modulate the p53 dependent apoptotic pathway to restrict AFB1 toxicity.

The involvement of AFB1 in DNA damage and its correlation with biomarkers of cellular oxidative stress and apoptosis induction were also evaluated in our work. Oxidative stress can be considered as an apoptosis inducer \[[@B73]\]. Many agents that induce apoptosis are either oxidants or stimulators of cellular oxidative metabolism. This is the case of AFB1which induced oxidative stress and apoptotic cell death.

It is concluded that CCE is hepatoprotective as it enhances the activities of liver function, as evidenced by the decrease in MDA, protein carbonyls generation and Hsp 70 and Hsp 27 levels, it showed a total reduction of AFB1 induced genotoxicity markers and decrease the expressions of pro-apoptotic proteins p53 and bax. The mode of action of CCE might be preventing or scavenging the formation of ROS. Therefore, this plant should be considered as an accessible source of natural antioxidants.

Our results are perfectly in coherence with other published reports, which underlined the relevant preventive potential of cactus extracts \[[@B74]\]. It could be very interesting to include the cactus pear in food diet. However, more investigations are needed to unveil the protective potential of cactus cladodes and to identify the specific therapeutic agents present in this plant.
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